Stock APO ACASTI PHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Acasti Pharma Inc Toronto S.E.

Equities

APO

CA00430K4028

Chart calendar Acasti Pharma Inc

550f67f7eb4dbc9fcf0de967fdf1f2.vcZQzC3eBgT6wa6zX0jHLv9czQfmg2FzYryc22M3Tfk.2v49qkO4dFKXr-fjFgmeFoY9o3Gu-wMJNI3SqzR8FLvWrBT0Sax8XbGt3Q~47239d8bcb72c3b599220f1f9fd8c5aa

Upcoming events on Acasti Pharma Inc

2024-06-17 Q4 2024 Earnings Release (Projected)
2024-08-07 Q1 2025 Earnings Release (Projected)
2024-11-10 Q2 2025 Earnings Release (Projected)
2025-02-16 Q3 2025 Earnings Release (Projected)

Past events on Acasti Pharma Inc

2024-02-12 08:00 am Q3 2024 Earnings Release
2024-02-07 International Stroke Conference
2024-01-09 LifeSci Partners Corporate Access Event
2024-01-07 Bio One On One Partnering Conference
2024-01-06 Sachs Neuroscience Innovation Forum
2023-11-13 08:00 am Q2 2024 Earnings Release
2023-10-11 02:00 pm Investor Meeting - Key Openion Leader
2023-10-10 01:00 pm Annual General Meeting
2023-09-11 02:00 pm H.C. Wainwright Global Investment Conference
2023-08-16 06:00 pm Neurocritical Care Society Meeting - Poster Number: 247
2023-08-11 07:00 am Q1 2024 Earnings Release
2023-06-23 07:00 am Q4 2023 Earnings Release
2023-05-18 02:00 pm Lytham Partners Spring Investor Conference - Panel
2023-05-18 09:00 am Lytham Partners Spring Investor Conference
2023-03-13 08:40 am Oppenheimer Healthcare Conference
2023-02-14 01:00 pm Q3 2023 Earnings Call
2023-02-14 07:00 am Q3 2023 Earnings Release
2023-01-31 09:00 am Lytham Partners virtual Investor Select Conference
2023-01-18 03:15 pm Sidoti Micro-Cap Virtual Conference
2023-01-10 04:30 pm GTX-101 and GTX-102 Phase 1 PK Studies Results Call

Annual results

Fiscal PeriodMarch 2019 2020 2021 2022 2023 2024
Net sales
Million CAD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million CAD		Released
Forecast
Spread 		-42,2
-18,3
-130.18%		0,00
0,00
- 		0,00


0,00
0,00
- 		0,00
0,00
-
-18,9

EBIT
Million CAD		Released
Forecast
Spread 		-45,0
-43,9
-2.44%		-30,6
-35,9
14.87%		0,00


-20,3
-21,5
5.92%		-24,6
-27,2
9.74%
-16,3

Earnings before Tax (EBT)
Million CAD		Released
Forecast
Spread 		0,00
0,00
- 		-34,9
-68,1
48.68%		0,00


-13,6
-14,9
8.76%		-68,4
-27,2
-151.55%
-19,6

Net income
Million CAD		Released
Forecast
Spread 		0,00
0,00
- 		-34,9
-68,1
48.68%		-24,3


-12,8
-14,9
14.41%		-55,9
-26,3
-112.7%
-18,4

EPS
CAD		Released
Forecast
Spread 		0,00
0,00
- 		-19,7
-38,2
48.43%		-10,1


-2,09
-1,07
-96.04%		-7,53
-3,56
-111.24%
-1,94

Announcement Date26/06/1929/06/2022/06/2121/06/2223/06/23-

Quarterly results

Fiscal PeriodMarch 2022 Q3 2022 Q4 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million CAD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBITDA
Million CAD		Released
Forecast
Spread

















-4,10
-3,24
-26.37%
-4,97


-4,97


-5,64


-5,64


-5,64

EBIT
Million CAD		Released
Forecast
Spread 		-5,67
-4,53
-25.4%		-5,72
-7,64
25.15%		-5,67
-7,79
27.27%		-6,01
-8,44
28.8%		-5,97
-6,63
10%		-2,89
-3,27
11.46%		-4,10
-3,51
-16.69%
-5,38


-5,38


-6,05


-6,05


-6,05

Earnings before Tax (EBT)
Million CAD		Released
Forecast
Spread 		-4,79
-4,53
-5.89%		-5,91
-7,64
22.62%		-5,56
-7,86
29.25%		-50,0
-8,44
-491.99%		-5,78
-6,40
9.67%		-5,14
-3,10
-66.12%		-3,50
-3,51
0.34%
-5,38


-5,38


-6,05


-6,05


-6,05

Net income
Million CAD		Released
Forecast
Spread 		-4,79
-4,53
-5.89%		-5,07
-7,64
33.64%		-5,19
-7,74
32.92%		-38,3
-8,44
-353.64%		-5,39
-6,21
13.13%		-4,53
-3,00
-50.7%		-3,22
-3,55
9.42%
-5,38


-5,38


-6,05


-6,05


-6,05

EPS
CAD		Released
Forecast
Spread 		-0,69
-0,62
-11.31%		-0,31
-1,00
68.86%		-0,72
-1,02
29.25%		-5,15
-1,13
-356.66%		-0,72
-0,84
13.44%		-0,59
-0,40
-50.59%		-0,28
-0,31
9.09%
-0,47


-0,36


-0,42


-0,42


-0,32

Announcement Date14/02/2221/06/2214/02/2323/06/2311/08/2313/11/2312/02/24-----

Upcoming sector events for Acasti Pharma Inc

2024-04-26 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
2024-04-26 NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
2024-04-26 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
2024-04-26 HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
2024-04-26 ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-26 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
2024-04-26 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
2024-04-26 NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
2024-04-26 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-26 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
More events

Past sector events for Acasti Pharma Inc

Today PKU HEALTHCARE CORP.,LTD.: Q4 2023 Earnings Release
Today SHANGHAI KAIBAO PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
Today SHANGHAI KAIBAO PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
Today SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD: Q4 2023 Earnings Release
Today BEIJING KONRUNS PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today BEXIMCO PHARMACEUTICALS LIMITED: Q3 2024 Earnings Release (Projected)
Today TORII PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today ABBVIE INC.: Q1 2024 Earnings Release
Today CHANGZHOU QIANHONG BIOPHARMA CO.,LTD: Q4 2023 Earnings Release
Today CHANGZHOU QIANHONG BIOPHARMA CO.,LTD: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. ACST Stock
  4. APO Stock
  5. Calendar Acasti Pharma Inc